Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 2/20 | 0.72 |
| ▸ | POLB | P06746 | 1/20 | 0.72 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.67 |
| ▸ | MAPT | P10636 | 5/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.66 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.62 |
| ▸ | GAA | P10253 | 2/20 | 0.62 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | USP2 | O75604 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.50 |
| ▸ | PDE7A | Q13946 | 1/20 | 0.50 |
| ▸ | GFER | P55789 | 1/20 | 0.49 |
| ▸ | ADK | P55263 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10921869 | 1.00 | RAB9A (0.72) | RAB9APOLBKDM4EMAPTALDH1A1 | |
| SCHEMBL10916324 | 0.88 | KDM4E (0.71) | RAB9APOLBKDM4EMAPTALDH1A1 | |
| SCHEMBL10917199 | 0.86 | KDM4E (0.76) | RAB9APOLBKDM4EMAPTALDH1A1 | |
| SCHEMBL29446457 | 0.84 | POLB (0.75) | RAB9APOLBKDM4EMAPTALDH1A1 | |
| SCHEMBL10920778 | 0.84 | POLB (1.00) | RAB9APOLBKDM4EMAPTALDH1A1 | |
| SCHEMBL10916592 | 0.81 | RAB9A (0.67) | RAB9APOLBKDM4EMAPTALDH1A1 | |
| SCHEMBL6282118 | 0.78 | MAPT (0.63) | RAB9APOLBKDM4EMAPTALDH1A1 | |
| SCHEMBL23601086 | 0.78 | KDM4E (0.61) | RAB9APOLBKDM4EMAPTALDH1A1 | |
| SCHEMBL8347824 | 0.78 | MEN1 (0.68) | RAB9AKDM4EMAPTALDH1A1SMN1; SMN2 | |
| SCHEMBL5928741 | 0.78 | KDM4E (0.65) | RAB9APOLBKDM4EMAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12564547-B2 | Compositions, formulations, and methods for skin treatment | ODDITY LABS, LLC (US) | 2026-03-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12564547-B2 | Compositions, formulations, and methods for skin treatment | MCOLN1, H1-0, APOL1 | RAB9A 3702/4885POLB 4098/4885KDM4E 2683/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.